Whitney McKinley
Nurse Practitioner · Great Falls, MTNPI 1861979965
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,964 of the $3,395 with a category attached, or 87.3%. It is spread thinly across 42 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,108, 3.8 times the $294 reported in 2021. Among nurse practitioner clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$351
- Novartis$304
- Astellas Pharma US Inc$272
- Genentech USA, Inc.$195
- Johnson & Johnson$186
- Incyte Corporation$164
- plus $2K from 36 others
What the payments were for
- Food & beverage$2,96487%
- Education$43113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 21 | $351 |
| Novartis | 18 | $304 |
| Astellas Pharma US Inc | 11 | $272 |
| Genentech USA, Inc. | 12 | $195 |
| Johnson & Johnson | 11 | $186 |
| Incyte Corporation | 8 | $164 |
| Seagen Inc. | 6 | $161 |
| AVEO Pharmaceuticals, Inc. | 5 | $160 |
| AstraZeneca | 8 | $118 |
| E.r. Squibb & Sons, L.L.C. | 7 | $117 |
| Pfizer | 7 | $108 |
| Amgen | 7 | $108 |
| Lilly USA, LLC | 3 | $106 |
| AbbVie | 6 | $106 |
| Bristol Myers Squibb | 6 | $98 |
| Recordati_rare_diseases_inc. | 1 | $66 |
| Blueprint Medicines Corporation | 4 | $61 |
| Sanofi | 3 | $53 |
| Beone Medicines USA, Inc. | 2 | $48 |
| Caris MPI, Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| GSK | 3 | $45 |
| Servier Pharmaceuticals LLC | 2 | $43 |
| Eisai Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Sobi, Inc | 2 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $27 |
| Iovance Biotherapeutics, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $19 |
| Geron Corporation | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| Novocure Inc. | 1 | $16 |
| Gilead | 1 | $16 |
| Springworks Therapeutics, Inc. | 1 | $16 |
| Exelixis Inc. | 1 | $15 |
| Foundation Medicine, Inc. | 1 | $15 |
| Myovant Sciences Inc. | 1 | $14 |
| Pharming Healthcare, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
How this compares
$3,395 in reported general payments places this provider in the 95th percentile of 357 nurse practitioner providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $10,050 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $819 |
| Pantoprazole Sodium | 47 | $476 |
| Triamcinolone Acetonide | 21 | $377 |
| Oxycodone Hcl | 23 | $353 |
| Tamoxifen Citrate | 12 | $344 |
| Ondansetron OdtOndansetron | 15 | $301 |
| Hydroxyurea | 12 | $249 |
| Levothyroxine Sodium | 11 | $142 |
| Gabapentin | 17 | $136 |
| Dexamethasone | 13 | $105 |
| Duloxetine Hcl | 14 | $77 |
| Lorazepam | 15 | $59 |
| Levofloxacin | 16 | $49 |
| Furosemide | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $108 | $10,05016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 357 nurse practitioner providers in Montana.
Other nurse practitioner in Great Falls
- Bowen TrystiansonGreat Falls$6K
- Amber MolnarGreat Falls$4K
- Jessica BosoGreat Falls$4K
- Elizabeth O'ConnorGreat Falls$3K
- Vilma HerreraGreat Falls$2K
- Carrie PowellGreat Falls$2K
- Martin CamachoGreat Falls$1K
- Gina HansenGreat Falls$1K
- Khi SoldanoGreat Falls$951
- Melanie BrownGreat Falls$833
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.